Digitisation | March 19, 2026
Roche unveils massive AI factory to supercharge drug development
The facility features 2,176 high-performance GPUs across the US and Europe
The facility features 2,176 high-performance GPUs across the US and Europe
The expanded program allows patients to fill prescriptions either at a local pharmacy or through home delivery via LillyDirect
The trial will enroll up to 42 patients in Finland across four cohorts
Desidustat tablets are a novel oral HIF-PHI approved for treating anaemia in non-dialysis adult CKD patients
The trial’s primary goal is to evaluate vipoglanstat’s effect on endometriosis-related pain during non-menstrual days
The expansion builds on Veristat’s work helping Chinese pharmaceutical firms such as Hansoh Pharma and CStone Pharmaceuticals
The protections extend through at least 2035, with the potential for further extensions
The trial met its primary endpoint, with patients receiving povetacicept achieving a 52.0% reduction in UPCR at Week 36
The study hit its primary goal, showing a statistically significant rise in participants achieving EASI-75
The company announced positive topline data from the Phase II ZUPREME-1 trial
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
